Posaconazole-Induced Hypokalemia (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0902; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Case Description A 64 year old female with acute myeloid leukemia on cytarabine was admitted for severe hypokalemia while taking posaconazole 300 mg daily for 17 days...Isavuconazonium was utilized for further neutropenic prophylaxis...As demonstrated, switching to a different antifungal can fully reverse this. However, as pozaconazole's half life is 15-35 hours and these patient often have a large K deficits, it may take several days for labs to normalize, necessitating close monitoring and agressive initial electrolyte repletion."
Acute Myelogenous Leukemia • Hematological Malignancies • Hypertension • Leukemia • Metabolic Disorders • Neutropenia
|
|
Richard Raymund Reyes Ragasa; Tomasz Beben
|